An overview of statistical and regulatory issues in the planning, analysis, and interpretation of subgroup analyses in confirmatory clinical trials.
about
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposesEstimates of subgroup treatment effects in overall nonsignificant trials: To what extent should we believe in them?Probability of success for phase III after exploratory biomarker analysis in phase II.A New Paradigm. "Learn - Learn More"; Dose-Exposure-Response at the Center of Drug Development and Regulatory Approval.Multiplicity considerations in subgroup analysis.
P2860
An overview of statistical and regulatory issues in the planning, analysis, and interpretation of subgroup analyses in confirmatory clinical trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
An overview of statistical and ...... confirmatory clinical trials.
@en
type
label
An overview of statistical and ...... confirmatory clinical trials.
@en
prefLabel
An overview of statistical and ...... confirmatory clinical trials.
@en
P1476
An overview of statistical and ...... confirmatory clinical trials.
@en
P2093
Robert Hemmings
P356
10.1080/10543406.2013.856747
P577
2014-01-01T00:00:00Z